{"page_content": "2020 CORPORATE SOCIAL RESPONSIBILITY REPORT78\nDear Communities\nABOUT SERVE TRANSFORM ADVANCE REDEFINE ETHICS & COMPLIANCE REPORTING INDEX   DISCLOSURE TITLE EXPLANATION OR LOCATION\nGENERAL DISCLOSURES\n102-01 Name of the organization Alexion Pharmaceuticals, Inc. \n102-02 Activities, brands, products, and servicesAlexion 2020 CSR Report, About Alexion, Page 8  \nAlexion 2020 Form 10-K, Item 1 (Business: Overview, Products and Development Programs)\n102-03 Location of headquarters Boston, Massachusetts, United States\n102-04 Location of operationsAlexion 2020 Form 10-K, Item 1 (Business: Manufacturing, Sales and Marketing);  \nItem 2 (Properties)\nAlexion 2020 CSR Report, About Alexion, Page 8\n102-05 Ownership and legal form Alexion\u2019s common stock is quoted on the Nasdaq Stock Market, LLC under the symbol \u201cALXN.\u201d\n102-06 Markets served Alexion 2020 Form 10-K, Item 1 (Business: Customers); Note 18 (Segment Information)\n102-07 Scale of the organizationAlexion 2020 Form 10-K, Item 1 (Business: Products and Development Programs, Employees);\nItem 2 (Properties); Item 6 (Selected Financial Data)\nAlexion 2020 CSR Report, About Alexion, Page 7 (Alexion At-A-Glance)\n102-08Information on employees  \nand other workersAlexion 2020 Form 10-K, Item 1 (Business: Employees)\nAlexion 2020 CSR Report, About Alexion, Page 7 (Alexion At-A-Glance); Advance Our People  \nand Our Company, Page 39 (Employee Data)\n102-09 Supply chainAlexion 2020 Form 10-K, Item 1 (Business: Manufacturing); Item 1A (Risk Factors: Risks Related  \nto Business Operations)\nAlexion 2020 CSR Report, Ethics & Compliance: Our Foundation, Page 72 (Holding Our \nSuppliers to High Standards)\n102-10Significant changes to the organization \nand its supply chainAlexion 2020 Form 10-K, Item 1 (Business: Overview, Clinical Development Programs);  \nItem 7 (Management\u2019s Discussion and Analysis of Financial Condition and Results of Operations: \nMerger Agreement with AstraZeneca, Recent Developments)GRI INDEX", "metadata": {"source": "NASDAQ_ALXN_2020.pdf", "page": 77, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}